Pathobiology of prediabetes in a biracial cohort (POP-ABC): Design and methods

Ethnicity and Disease

Volumn 21, Issue 1, 2011, Pages 33-39

  Dagogo Jack, Samuel ^a   Edeoga, Chimaroke ^a   Nyenwe, Ebenezer ^a   Chapp Jumbo, Emmanuel ^a   Wan, Jim ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Betacell function; Body composition; Diabetes offspring; Energy expenditure; Ethnic disparities; Genetics; Insulin sensitivity; Pathogenesis; Prospective study

Indexed keywords

ADIPONECTIN; C PEPTIDE; C REACTIVE PROTEIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

AFRICAN AMERICAN; ALBUMINURIA; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMISTRY; BLOOD CELL COUNT; BLOOD CHEMISTRY; BODY COMPOSITION; CALORIMETRY; CAUCASIAN; CLINICAL RESEARCH; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); DISEASE SURVEILLANCE; ETHNIC DIFFERENCE; FOLLOW UP; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; HEREDITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IN VIVO STUDY; INCIDENCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PARENT; PATHOPHYSIOLOGY; PATIENT MONITORING; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PROGENY; RISK ASSESSMENT; SOCIOECONOMICS; ADOLESCENT; ADULT; AGED; BIOASSAY; COMPARATIVE STUDY; DISEASE COURSE; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ENDPOINT DETERMINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PATIENT SELECTION; PREDIABETIC STATE; RESEARCH DESIGN; RISK FACTORS; UNITED STATES;

EID: 79955105913     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin-dependent diabetes. In: Diabetes In America. 2nd ed. Bethesda, MD: National Diabetes Data Group, NIH, 1995;47-67.
2. Centers for Disease Control and Prevention. Diabetes Data and Trends. Available at: http:// www.cdc.gov/diabetes/statistics/prevalence- national.htm. Last accessed on September 20, 2010.
3. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care. 2000;23:1278-1283.
4. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
5. Froguel P, Hager J. Human diabetes and obesity: tracking down the genes. Trends Biotechnol. 1995;13:52-55.
6. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. http://www.nature.com/ng/journal/v42/ n7/pdf/ng.609.pdf - a5#a5 Nat Genet. 2010; 42:579-589.
7. Neel JV, Weder AB, Julius S. Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med. 1998;42:44-74.
8. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med. 1993;329:1988-1992. (Pubitemid 24015042)
9. Lillioja S, Bogardus C. Obesity and insulin resistance: lessons learned from the Pima Indians. Diabet Metab Rev. 1988;4:517-540.
10. Weyer C, Bogardus C, Mott DM, Pratley R. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104:787-794. (Pubitemid 29536364)
11. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6:1-27. (Pubitemid 20329348)
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-3167.
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197.
14. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva: World Health Org. (Tech. Rep. Ser., no. 727); 1985.
15. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007;369:201-207. (Pubitemid 46111014)
16. Mayer-Davis EJ, Vitolins MZ, Carmichael SL, et al. Validity and reproducibility of a food frequency interview in a multi-cultural epidemiology study. Ann Epidemiol. 1999;9:314-324. (Pubitemid 29289846)
17. Kriska AM, Caspersen CJ. Introduction to a collection of physical activity questionnaires. Med Sci Sports Exerc. 1997;29:Suppl:S5-S9.
18. Haffner SM, Hazuda HP, Stern MP, et al. Effects of socioeconomic status on hyperglycemia and retinopathy in Mexican Americans with NIDDM. Diabetes Care. 1989;12:128-134. (Pubitemid 19064406)
19. Gornick ME. Measuring the effect of socioeconomic status on health care. In: Swift EK ed. Guidance for the National Healthcare Disparities Report, Institute of Medicine. Washington, DC: The National Academy Press, 2002;45-73.
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223. (Pubitemid 9249478)
21. DelPrato S, Ferrannini E, DeFronzo R. Evaluation of insulin sensitivity in man. In: Clark W, Larner J, Pohl S, eds. Methods in Diabetes Research, Vol II, Clinical Methods. New York: Wiley and Sons, 1984;35-77.
22. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol (Lond). 1949;109:1-9.
23. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism. 1988;37(3):287-301. (Pubitemid 18080935)
24. Weyer C, Snitker S, Bogardus C, Ravussin E. Energy metabolism in African Americans: potential risk factors for obesity. Am J Clin Nutr. 1999;70:13-20. (Pubitemid 29461107)
25. Jakicic JM, Wing RR. Differences in resting energy expenditure in African American vs. Caucasian overweight females. Int J Obes Relat Metab Disord. 1998;22:236-242. (Pubitemid 28112024)
26. Dagogo-Jack S, Selke G, Melson AK, Newcomer JW. Robust leptin secretory responses to dexamethasone in obese subjects. J Clin Endocrinol Metab. 1997;82:3230-3233. (Pubitemid 27419062)
27. Tull ES, Roseman JM. Diabetes in African Americans. In: Diabetes In America, 2nd ed. Bethesda, MD: National Diabetes Data Group, NIH, 1995;613-629.
28. Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology: a Practical Guide. Cambridge: University Press; 2003.
29. Dagogo-Jack S, Santiago JV. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med. 1997;157:1802-1817. (Pubitemid 27381112)
30. DeFronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773-795.
31. Brancati FL, Kao WHL, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults. JAMA. 2000;283:2253-2259.
32. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34:1055-1058. (Pubitemid 16236528)
33. Reaven GM, Hollenbeck CB, Chen YDI. Relationship between glucose tolerance, insulin secretion and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia. 1989;32:52-55. (Pubitemid 19061742)
34. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA. The metabolic profile of NIDDMis fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes. 1992;41:1575-1586.
35. Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. J Clin Invest. 1994;94:1714-1721.
36. Osei K, Schuster DP, Owusu SK, Amoah AGB. Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African ancestry and White Americans. Metabolism. 1997;46:53-58. (Pubitemid 27052024)
37. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanic Whites. Diabetes. 1996;45:742-748.
38. Mbanya JC, Pani LN, Mbanya DN, Sobngwi E, Ngogang J. Reduced insulin secretion in offspring of African type 2 diabetic parents. Diabetes Care. 2000;23:1761-1765.
39. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med. 1989;321:337-343. (Pubitemid 19190437)
40. Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulindependent diabetes mellitus. J Clin Invest. 1995;95:690-698.
41. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes. 1997;46:701-710. (Pubitemid 27143390)
42. Motala AA, Omar MA, Gouws E. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM. Diabetes Care. 1997;20:1101-1107. (Pubitemid 27274270)